4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      From presentation to paper: Gender disparities in oncological research

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Gender disparities in scientific publications have been identified in oncological research. Oral research presentations at major conferences enhance visibility of presenters. The share of women presenting at such podia is unknown. We aim to identify gender‐based differences in contributions to presentations at two major oncological conferences. Abstracts presented at plenary sessions of the American Society of Clinical Oncology (ASCO) Annual Meetings and European Society for Medical Oncology (ESMO) Congresses were collected. Trend analyses were used to analyze female contribution over time. The association between presenter's sex, study outcome (positive/negative) and journals' impact factors (IFs) of subsequently published papers was assessed using Chi‐square and Mann–Whitney U tests. Of 166 consecutive abstracts presented at ASCO in 2011–2018 ( n = 34) and ESMO in 2008–2018 ( n = 132), 21% had female presenters, all originating from Northern America ( n = 17) or Europe ( n = 18). The distribution of presenter's sex was similar over time ( p = 0.70). Of 2,425 contributing authors to these presented abstracts, 28% were women. The proportion of female abstract authors increased over time ( p < 0.05) and was higher in abstracts with female (34%) compared to male presenters (26%; p < 0.01). Presenter's sex was not associated with study outcome ( p = 0.82). Median journals' IFs were lower in papers with a female first author ( p < 0.05). In conclusion, there is a clear gender disparity in research presentations at two major oncological conferences, with 28% of authors and 21% of presenters of these studies being female. Lack of visibility of female presenters could impair acknowledgement for their research, opportunities in their academic career and even hamper heterogeneity in research.

          Abstract

          What's new?

          Presenting one's research at a conference is a great way to get your name and ideas heard within the professional community. In this study, the authors investigated how often women served as presenters at plenary sessions of ASCO Annual Meetings and ESMO Congresses. Looking through 166 abstracts over a period of 8 years, they found that 21% had female presenters, while 28% of study authors were female. Lack of visibility for female researchers at conferences can slow their career progress, and greater representation should be encouraged.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: not found
          • Article: not found

          Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The Gender Citation Gap in International Relations

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Gender practices in the construction of academic excellence: Sheep with five legs

                Bookmark

                Author and article information

                Contributors
                h.vanlaarhoven@amsterdamumc.nl
                Journal
                Int J Cancer
                Int. J. Cancer
                10.1002/(ISSN)1097-0215
                IJC
                International Journal of Cancer
                John Wiley & Sons, Inc. (Hoboken, USA )
                0020-7136
                1097-0215
                11 October 2019
                01 June 2020
                : 146
                : 11 ( doiID: 10.1002/ijc.v146.11 )
                : 3011-3021
                Affiliations
                [ 1 ] Department of Medical Oncology Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam Amsterdam The Netherlands
                [ 2 ] Department of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht The Netherlands
                [ 3 ] Department of Medical Oncology National Cancer Centre Singapore Singapore Singapore
                [ 4 ] Division of Medical Oncology, Department of Medicine Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok Thailand
                [ 5 ] Department of Medical Oncology Hospital General Universitario Gregorio Marañón Madrid Spain
                [ 6 ] Division of Cancer Sciences Manchester Cancer Research Centre, University of Manchester Manchester United Kingdom
                [ 7 ] Department of Medical Oncology The Christie NHS Foundation Trust Manchester United Kingdom
                [ 8 ] Department of Medical Oncology University of Groningen, University Medical Center Groningen Groningen The Netherlands
                [ 9 ] The Royal Marsden NHS Foundation Trust London United Kingdom
                [ 10 ] Institute for Oncology and Radiology of Serbia Belgrade Serbia
                [ 11 ] Institut Universitaire du Cancer de Toulouse (IUCT) Toulouse France
                Author notes
                [*] [* ] Correspondence to: Hanneke W.M. van Laarhoven, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands, Tel.: +31‐20‐5665955, Fax: +31‐20‐6919743, E‐mail: h.vanlaarhoven@ 123456amsterdamumc.nl
                Author information
                https://orcid.org/0000-0002-3516-6743
                Article
                IJC32660
                10.1002/ijc.32660
                7187424
                31472016
                9c66ce41-fb7d-4e5a-94ae-f79b6fc5ee35
                © 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 07 June 2019
                : 22 July 2019
                : 07 August 2019
                Page count
                Figures: 2, Tables: 2, Pages: 11, Words: 9077
                Categories
                Cancer Epidemiology
                Cancer Epidemiology
                Custom metadata
                2.0
                1 June 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.1 mode:remove_FC converted:28.04.2020

                Oncology & Radiotherapy
                research,medical oncology,sex,congresses as topic
                Oncology & Radiotherapy
                research, medical oncology, sex, congresses as topic

                Comments

                Comment on this article